analyst

NASDAQ · IDYA
IDEAYA Biosciences, Inc.
Healthcare · Biotechnology
$39.71
Up+$0.85 (+2.19%)
Updated Sep 23, 2026, 4:01 AM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 2.94B
- P/E ratio
- -8.97
- Dividend yield
- 0.00%
- 52-week range
- $25.27 – $42.68
- Volume
- 745.79K
- Avg. volume
- 1.13M
Price performance
IDYA price history
1M range · 20 trading sessions · Daily adjusted prices
IDYA closed at $39.71 after 20 trading sessions, down 6.52% for the selected period.
- Last close
- $39.71
- Period change
- -6.52%
- Period low
- $37.45
- Period high
- $42.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $39.11 | $40.00 | $38.93 | $39.71 | 745.79K |
| Sep 21, 2026 | $38.705 | $39.00 | $37.985 | $38.86 | 571.1K |
| Sep 18, 2026 | $38.88 | $39.245 | $38.15 | $38.41 | 2.49M |
| Sep 17, 2026 | $38.61 | $39.47 | $38.53 | $38.61 | 757.77K |
| Sep 16, 2026 | $37.71 | $38.46 | $37.24 | $37.73 | 639.91K |
| Sep 15, 2026 | $37.88 | $38.24 | $37.125 | $37.66 | 654.23K |
| Sep 14, 2026 | $38.50 | $39.33 | $37.74 | $38.03 | 524.74K |
| Sep 11, 2026 | $37.74 | $38.27 | $37.24 | $37.59 | 429.25K |
| Sep 10, 2026 | $37.85 | $38.405 | $37.37 | $37.45 | 547.79K |
| Sep 9, 2026 | $39.19 | $39.19 | $38.21 | $38.35 | 488.55K |
| Sep 8, 2026 | $38.90 | $39.4699 | $38.59 | $38.84 | 805.96K |
| Sep 4, 2026 | $39.55 | $40.0699 | $39.42 | $39.86 | 448.01K |
| Sep 3, 2026 | $40.41 | $40.665 | $39.56 | $39.97 | 567.9K |
| Sep 2, 2026 | $40.20 | $41.48 | $39.58 | $40.17 | 765.29K |
| Sep 1, 2026 | $39.85 | $40.20 | $38.90 | $39.95 | 587.8K |
| Aug 31, 2026 | $39.74 | $40.32 | $39.43 | $40.10 | 977.81K |
| Aug 28, 2026 | $41.14 | $41.635 | $40.04 | $40.11 | 714.07K |
| Aug 27, 2026 | $41.63 | $42.095 | $40.965 | $41.77 | 534.41K |
| Aug 26, 2026 | $42.26 | $42.325 | $41.09 | $41.58 | 724.9K |
| Aug 25, 2026 | $40.88 | $42.68 | $40.06 | $42.48 | 1.02M |
Latest IDYA news
The latest Smart Investors Daily articles mentioning IDYA.
Stock researchResearch & News · SEC Filings
Loading stock research…

